MIGDAL HA'EMEQ, Israel, Nov. 14, 2013 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-functional lipid ingredients, announced today that Dr. Ariel Katz, the Company's President and Chief Executive Officer, will be presenting at the Jefferies 2013 Global Healthcare Conference to be held on November 20-21, 2013 in London, UK.
Enzymotec's presentation is scheduled for Wednesday, November 20, at 3:40 PM UK Time (10:40 AM Eastern Time).
The audio portion of the presentation will be webcast live, and a replay will be available on the Investors section of the Company's website at www.enzymotec.com.
About Enzymotec Ltd.
Enzymotec is a leading global supplier of specialty lipid-based products and solutions. The Company develops, manufactures and markets innovative bio-functional lipid ingredients, as well as final products, based on sophisticated processes and technologies.